Sanjana Ballal
New Delhi, DL 110029, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 91 publications
Homomultimeric FAP Inhibitor-Based Radioligands for Cancer Theranostics: Design Principles, Structure-Function Relationships, and Preclinical Performance.
Journal: Molecules (Basel, Switzerland)
Published: April 21, 2026
Comparative Evaluation of [68Ga]Ga-DOTA.SA.FAPi and [18F]FDG PET/CT in Metastatic Breast and Lung Cancer: Semiquantitative, Volumetric and Prognostic Assessment.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: January 29, 2026
Radioiodine Plus Low-Dose Lenvatinib in Radioiodine-Sensitive High-Volume Metastatic Differentiated Thyroid Cancer: A Pilot Study.
Journal: Clinical nuclear medicine
Published: July 31, 2025
Efficacy and Safety of [177Lu]Lu-DOTAGA.Glu.(FAPi)2 Therapy in Patients with Sarcoma.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: April 14, 2025
Diagnostic Accuracy of [68Ga]GaNOTA-Ubiquicidin PET-CT for Differentiating Infections from Cancer in Oncology Practice: Preliminary Results from a Pilot Study.
Journal: Nuclear medicine and molecular imaging
Published: March 14, 2025
Targeted Radionuclide Therapy in Diffuse Intrinsic Brainstem Gliomas: Exploring Options Beyond the Finish Line.
Journal: Clinical nuclear medicine
Published: February 19, 2025
Long-Term Outcomes in Radioiodine-Resistant Follicular Cell-Derived Thyroid Cancers Treated with [177Lu]Lu-DOTAGA.FAPi Dimer Therapy.
Journal: Thyroid : official journal of the American Thyroid Association
Published: January 27, 2025
Biodistribution and Dosimetry Evaluation of the Radiolabeled Somatostatin Receptor Antagonist 68 Ga-DATA 5m LM4 in Molecular Imaging of Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors Patients.
Journal: Clinical nuclear medicine
Published: January 06, 2025
Clinical Outcomes of 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy in Patients with Skeletal Metastases from Neuroendocrine Tumors: Insights from Real-World Experience.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: January 03, 2025
Improved FAPI-radiopharmaceutical pharmacokinetics from the perspectives of a dose escalation study.
Improved FAPI-radiopharmaceutical pharmacokinetics from the perspectives of a dose escalation study.
Journal: European journal of nuclear medicine and molecular imaging
Published: November 01, 2024
Head-to-Head Comparison Between [ 68 Ga]Ga-DOTA.SA.FAPi And [ 18 F]F-FDG PET/CT Imaging in Patients With Sarcoma.
Journal: Clinical nuclear medicine
Published: October 27, 2024
Last Updated: 09/26/2026